Comparison of Ultrasound-guided Transverse Carpal Ligament Needle Release Via Different Approaches for Patients With Mild-to-moderate Carpal Tunnel Syndrome
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Carpal Tunnel Syndrome
- Sponsor
- Peking University People's Hospital
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- visual analogue scale(VAS) scores
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Carpal tunnel syndrome (CTS) is one of the most common peripheral nerve entrapment neuropathies, and it is characterized by pain, numbness, tingling, and weakness in the regions innervated by the median nerve (MN). CTS is believed to result from compression of the MN as it passes through the narrowed carpal tunnel with regard to gradual ischemia and fibrosis.Ultrasound-guided needle release of transverse carpal ligament(TCL) is an effective method to decompress the carpal.There are two main approaches to perform the release, short-axis or long-axis. However, there is no consensus about the optimal strategy.Thus, this study aimed to compare the efficacy of these two approaches for patients with mild-to-moderate CTS.
Investigators
Zhu Jiaan
Professor
Peking University People's Hospital
Eligibility Criteria
Inclusion Criteria
- •18-80 years old
- •typical clinical signs of CTS present for at least three months, including pain, numbness, and tingling of the hands
- •positive Phalen or Tinel sign
- •electrophysiological parameters supportive of mild to moderate CTS
- •high-resolution ultrasonography demonstrated MN compression at the carpal.
Exclusion Criteria
- •bifid MN or bilateral CTS
- •pregnancy
- •disorders such as rheumatic immune diseases, chronic renal failure, diabetes mellitus, hypothyroidism and other systemic diseases
- •any accompanying disorder that could mimic CTS, such as thoracic outlet syndrome, cervical radiculopathy, polyneuropathy, proximal median nerve entrapment
- •history of carpal tunnel surgery or injection into the affected carpal tunnel
- •CTS caused by trauma, surgery, intracarpal lesions, or MN lesions malignant tumors or severe cardiorespiratory diseases
Outcomes
Primary Outcomes
visual analogue scale(VAS) scores
Time Frame: Baseline as well as 1 month, 3 month and 6 months after injection.
The VAS scores is the most common tool to assess the level of pain. Possible scores range from 0(no pain) to 10(worst possible pain).
Secondary Outcomes
- cross-sectional area(CSA) of the median nerve(Baseline as well as 1 month, 3 month and 6 months after injection.)
- Boston carpal tunnel syndrome questionnaire(BCTQ)(Baseline as well as 1 month, 3 month and 6 months after injection.)